Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides

Vaccine

Volumn 28, Issue 39, 2010, Pages 6425-6435

  Wu, Yang ^a   Zhang, Qibo ^b   Sales, Debra ^b   Bianco, Albert Edward ^a   Craig, Alister ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antibody; Bacteria; Capsular polysacchride; Mimotope; Vaccine

Indexed keywords

ASPARAGINYLPROLYLASPARTYLHISTIDYLPROLYLARGINYLVALYLPROLYLTHREONYLPHENYLALANYLMETHIONYLALANINE; BACTERIAL POLYSACCHARIDE; DNA VACCINE; GLUTAMYLGLUTAMINYLGLUTAMYLISOLEUCYLPHENYLALANYLTHREONYLASPARAGINYLISOLEUCYLTHREONYLASPARTYLARGINYLVALINE; LEUCYLISOLEUCYLPROLYLPHENYLALANYLHISTIDYLLYSYLHISTIDYLPROLYLHISTIDYLHISTIDYLARGINYLGLYCINE; OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL MEMBRANE; CROSS REACTION; DNA IMMUNIZATION; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; SURFACE PROPERTY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; ANTIBODY FORMATION; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE LIBRARY; PEPTIDES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS AGALACTIAE; VACCINES, DNA; VACCINES, SUBUNIT;

EID: 77956418421     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.049     Document Type: Article

References (50)

1. Austrian R. Polysaccharide vaccines. Ann Inst Pasteur Microbiol 1985, 136B:295-307.
2. Lesinski G.B., Westerink M.A. Vaccines against polysaccharide antigens. Curr Drug Targets Infect Disord 2001, 1:325-334.
3. Bondada S., Garg M. Handbook of B and T lymphocytes 1994, Academic Press, New York, NY. E.C. Snow (Ed.).
4. Loughlin A.M., Marchant C.D., Lett S., Shapiro E.D. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age. Pediatr Infect Dis J 1992, 11:374-379.
5. Romero-Steiner S., Musher D.M., Cetron M.S., Pais L.B., Groover J.E., Fiore A.E., et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999, 29:281-288.
6. Lesinski G.B., Westerink M.A. Novel vaccine strategies to T-independent antigens. J Microbiol Methods 2001, 47:135-149.
7. Baker C.J., Edwards M.S. Group B streptococcal conjugate vaccines. Arch Dis Child 2003, 88:375-378.
8. Pollard A.J., Perrett K.P., Beverley P.C. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 2009, 9:213-220.
9. Agadjanyan M., Luo P., Westerink M.A., Carey L.A., Hutchin W., Steplewski Z., et al. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat Biotechnol 1997, 15:547-551.
10. Monzavi-Karbassi B., Cunto-Amesty G., Luo P., Kieber-Emmons T. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol 2002, 20:207-214.
11. Harris S.L., Craig L., Mehroke J.S., Rashed M., Zwick M.B., Kenar K., et al. Exploring the basis of peptide-carbohydrate cross-reactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc Natl Acad Sci USA 1997, 18:2454-2459.
12. Kieber-Emmons T., Luo P., Qiu J., Agadjanyan M., Carey L., Hutchins W., et al. Peptide mimicry of adenocarcinoma-associated carbohydrate antigens. Hybridoma 1997, 16:3-10.
13. Phalipon A., Folgori A., Arondel J., Sgaramella G., Fortugno P., Cortese R., et al. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol 1997, 27:2620-2625.
14. Pincus S.H., Smith M.J., Jennings H.J., Burritt J.B., Glee P.M. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. J Immunol 1998, 160:293-298.
15. Westerink M.A., Giardina P.C., Apicella M.A., Kieber-Emmons T. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci USA 1995, 92:4021-4025.
16. Geysen H.M., Rodda S.J., Mason T.J., Tribbick G., Schoofs P.G. Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987, 102:259-274.
17. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356:152-154.
18. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1995, 1:583-586.
19. Xu D., Liew F.Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp 63 of Leishmania major. Immunology 1995, 84:173-176.
20. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 1994, 91:9866-9870.
21. Costa F., Franchin G., Pereira-Chioccola V.L., Ribeirão M., Schenkman S., Rodrigues M.M. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 1998, 16:768-775.
22. Ulmer J.B., Donnelly J.J., Suezanne E., Parker S.E., Rhodes G.H., Feigner P.L., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259:1745-1749.
23. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997, 3:526-532.
24. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes virus 2 disease. Proc Natl Acad Sci USA 1996, 93:11414-11420.
25. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nat Med 1996, 2:888-893.
26. Xu L., Sanchez A., Yang Z., Zaki S.R., Nabel E.G., Nichol S.T., et al. Immunization for Ebola virus infection. Nat Med 1998, 4:37-42.
27. Harrison R.A., Wu Y., Egerton G., Bianco A.E. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice. Vaccine 1999, 18:647-655.
28. Harrison R.A., Bianco A.E. DNA immunization with Onchocerca volvulus genes. Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis. Parasite Immunol 2000, 22:249-257.
29. Eisenbraun M.D., Fuller D.H., Haynes J.R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 1993, 12:791-797.
30. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997, 158:2278-2284.
31. Boyle J.S., Silva A., Brady J.L., Lew M.A. DNA immunization: induction of higher avidity antibody and the effect of route on T cell cytotoxicity. Proc Natl Acad Sci USA 1997, 94:14626-14631.
32. Davis H.L., Michel M.L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993, 2:1847-1851.
33. Lesinski G.B., Smithson S.L., Srivastava N., Chen D., Widera G., Westerink M.A. A DNA vaccine encoding peptide mimics of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine 2001, 19:1717-1726.
34. Kieber-Emmons T., Monzavi-Karbassi B., Wang B., Luo P., Weiner D.B. Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response. J Immunol 2000, 165:623-627.
35. Monzavi-Karbassi B., Shamloo S., Kieber-Emmons M., Jousheghany F., Luo P., Lin K.Y., et al. Priming characteristics of peptide mimotopes of carbohydrate antigens. Vaccine 2003, 21:753-760.
36. Haynes J.R., Fuller D.H., Eisenbraun M.D., Ford M.J., Pertmer T.M. Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses. AIDS Res Hum Retroviruses 1994, 2(10 Suppl.):S43-S45.
37. Valmori D., Pessi A., Bianchi E., Corradin G. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J Immunol 1992, 149:717-721.
38. Finn A., Zhang Q.B., Seymour L., Fasching C., Pettitt E., Janoff E.N. Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides. J Infect Dis 2002, 186:1422-1429.
39. Vermont C.L., van Dijken H.H., van Limpt C.J., de Groot R., van Alphen L., van Den Dobbelsteen G.P. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun 2002, 70:584-590.
40. Zhang Q.B., Choo S., Everard J., Jennings R., Finn A. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun 2000, 68:2692-2697.
41. Wu Y., Egerton G., Pappin D.J., Harrison R.A., Wilkinson M.C., Underwood A., et al. The secreted larval acidic proteins (SLAPs) of Onchocerca spp. are encoded by orthologues of the alt gene family of Brugia malayi and have host protective potential. Mol Biochem Parasitol 2004, 134:213-224.
42. Monzavi-Karbassi B., Cunto-Amesty G., Luo P., Lees A., Kieber-Emmons T. Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies. Biologicals 2001, 29:249-257.
43. Luo P., Canziani G., Cunto-Amesty G., Kieber-Emmons T. A molecular basis for functional peptide mimicry of a carbohydrate antigen. J Biol Chem 2000, 275:16146-16154.
44. Rodgers G.L., Arguedas A., Cohen R., Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 2009, 27:3802-3810.
45. Tai S.S. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol 2006, 32:139-153.
46. Lauterbach H., Gruber A., Ried C., Cheminay C., Brocker T. Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination. J Immunol 2006, 176:4600-4607.
47. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 1997, 94:9378-9383.
48. McShane H. Prime-boost immunization strategies for infectious diseases. Curr Opin Mol Ther 2002, 4:23-27.
49. Jensen T., Hansen P., Galli-Stampino L., Mouritsen S., Frische K., Meinjohanns E., et al. Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide. J Immunol 1997, 158:3769-3778.
50. Galli-Stampino L., Meinjohanns E., Frische K., Meldal M., Jensen T., Werdelin O., et al. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res 1997, 57:3214-3222.